The New Hampshire hospital allegedly received referrals worth "millions of dollars."

The deal, originally announced back in July 2021, valued the new entity at approximately $2.4 billion.

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

Getinge announced its planned to acquire 100% of the equity interest in Talis Clinical, which provides high-acuity IT software applications for critical care, cardiac surgery/perfusion and extracorporeal membrane oxygenation.

The organization issued a draft of its recommendation back in April, leaving time for public comments to be made. 

TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."

The document, available in full for free, is the result of a collaboration with the Consumer Technology Association.